Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion.
- 1 May 2001
- journal article
- review article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 109 (suppl 2) , 291-300
- https://doi.org/10.1289/ehp.01109s2291
Abstract
We review the hepatocarcinogenic effects of fungal cultures of Fusarium verticillioides(= Fusarium moniliforme) strain MRC 826 in male BD IX rats. Subsequent chemical analyses of the fumonisin B (FB) mycotoxin content in the culture material used and long-term carcinogenesis studies with purified FB1 provide information about dose-response effects, relevance of hepatotoxicity during FB1-induced carcinogenesis, and the existence of a no-effect threshold. Fumonisin intake levels of between 0.08 and 0.16 mg FB/100 g body weight (bw)/day over approximately 2 years produce liver cancer in male BD IX rats. Exposure levels < 0.08 mg FB/100 g bw/day fail to induce cancer, although mild toxic and preneoplastic lesions are induced. The nutritional status of the diets used in the long-term experiments was marginally deficient in lipotropes and vitamins and could have played an important modulating role in fumonisin-induced hepatocarcinogenesis. Short-term studies in a cancer initiation/promotion model in rat liver provided important information about the possible mechanisms involved during the initial stages of cancer development by this apparently nongenotoxic mycotoxin. These studies supported the findings of long-term investigations indicating that a cytotoxic/proliferative response is required for cancer induction and that a no-effect threshold exists for cancer induction. The mechanisms proposed for cancer induction are highlighted and include the possible role of oxidative damage during initiation and the disruption of lipid metabolism, integrity of cellular membranes, and altered growth-regulatory responses as important events during promotion.Keywords
This publication has 75 references indexed in Scilit:
- Fumonisin B1influenced the effects of arachidonic acid, prostaglandins E2 and A2 on cell cycle progression, apoptosis induction, tyrosine- and CDC2-kinase activity in oesophageal cancer cellsProstaglandins, Leukotrienes & Essential Fatty Acids, 2000
- Regulation of fatty acid biosynthesis as a possible mechanism for the mitoinhibitory effect of fumonisin B1in primary rat hepatocytesProstaglandins, Leukotrienes & Essential Fatty Acids, 1999
- The cancer-promoting potential of fumonisin B1 in rat liver using diethylnitrosamine as a cancer initiatorCancer Letters, 1996
- Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: Involvement of protein tyrosine kinase and protein kinase CHepatology, 1996
- Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: Involvement of protein tyrosine kinase and protein kinase CHepatology, 1996
- Fumonisin B1 dosimetry in relation to cancer initiation in rat liverCarcinogenesis: Integrative Cancer Research, 1994
- Hepatocyte growth factor has potent anti‐proliferative activity in various tumor cell linesFEBS Letters, 1991
- Quantitative Determination of Fumonisins B1and B2by High-Performance Liquid Chromatography with Fluorescence DetectionJournal of Liquid Chromatography, 1990
- Hepato- and cardiotoxicity of Fusarium verticillioides (F. moniliforme) isolates from Southern African maizeFood and Cosmetics Toxicology, 1981
- Causative fungus agent of leucoencephalomalacia in equine animalsPublished by Wiley ,1971